Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
Importance COVID-19 is associated with clinically significant symptoms despite resolution of
the acute infection (ie, post-COVID-19 syndrome). Fatigue and cognitive impairment are …
the acute infection (ie, post-COVID-19 syndrome). Fatigue and cognitive impairment are …
International consensus statement on allergy and rhinology: rhinosinusitis 2021
RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia
Altered olfactory function is a common symptom of COVID-19, but its etiology is unknown. A
key question is whether SARS-CoV-2 (CoV-2)–the causal agent in COVID-19–affects …
key question is whether SARS-CoV-2 (CoV-2)–the causal agent in COVID-19–affects …
Neurological manifestations of COVID‐19: a systematic review and current update
A Whittaker, M Anson, A Harky - Acta Neurologica …, 2020 - Wiley Online Library
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),
was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak …
was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak …
COVID-19 and the chemical senses: supporting players take center stage
The main neurological manifestation of COVID-19 is loss of smell or taste. The high
incidence of smell loss without significant rhinorrhea or nasal congestion suggests that …
incidence of smell loss without significant rhinorrhea or nasal congestion suggests that …
Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19–positive patients compared to subjective methods: A systematic review …
ME Hannum, VA Ramirez, SJ Lipson… - Chemical …, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …
[HTML][HTML] Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
The emergence of SARS-CoV-2 has created an international health crisis, and small animal
models mirroring SARS-CoV-2 human disease are essential for medical countermeasure …
models mirroring SARS-CoV-2 human disease are essential for medical countermeasure …
Evolving phenotypes of non-hospitalized patients that indicate long COVID
Abstract Background For some SARS-CoV-2 survivors, recovery from the acute phase of the
infection has been grueling with lingering effects. Many of the symptoms characterized as …
infection has been grueling with lingering effects. Many of the symptoms characterized as …
Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments
R Najafloo, J Majidi, A Asghari… - ACS Chemical …, 2021 - ACS Publications
The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …
[PDF][PDF] Six month follow-up of self-reported loss of smell during the COVID-19 pandemic
Introduction: Loss of smell and taste is now recognised as amongst the most common
symptoms of COVID-19 and the best predictor of COVID-19 positivity. Long term outcomes …
symptoms of COVID-19 and the best predictor of COVID-19 positivity. Long term outcomes …